93 related articles for article (PubMed ID: 22106117)
1. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
2. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
J Dermatol; 2024 Jun; 51(6):869-872. PubMed ID: 38214494
[TBL] [Abstract][Full Text] [Related]
3. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.
Zhou Y; Zhou X; Feng X; Xia D; Qian H; Liu H; Li X; Li W
Front Immunol; 2023; 14():1201163. PubMed ID: 37325615
[TBL] [Abstract][Full Text] [Related]
5. Linear IgA bullous dermatosis associated with immunotherapy.
Momin B; Nguyen TF; Glade D; Messer A
Dermatol Online J; 2023 Dec; 29(6):. PubMed ID: 38478666
[TBL] [Abstract][Full Text] [Related]
6. Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice.
Jing K; Jordan TJM; Li N; Burette S; Yang B; Marinkovich MP; Diaz LA; Googe P; Thomas NE; Feng S; Liu Z
J Invest Dermatol; 2024 Jan; 144(1):24-32.e1. PubMed ID: 37437774
[TBL] [Abstract][Full Text] [Related]
7. IgA autoantibody may be the foremost pathogenic in three cases of linear IgA/IgG bullous dermatosis.
Jing K; Wang Y; Li S; Feng S
Australas J Dermatol; 2023 Aug; 64(3):e224-e228. PubMed ID: 37403826
[TBL] [Abstract][Full Text] [Related]
8. Indirect immunofluorescence for bullous pemphigoid using ex vivo confocal laser scanning microscopy.
Bağcı IS; Ergün EZ; Avci P; Aoki R; Krammer S; Vladimirova G; Sárdy M; Ruzicka T; Hartmann D
J Dermatol; 2023 Aug; 50(8):e236-e237. PubMed ID: 36914975
[No Abstract] [Full Text] [Related]
9. Unusual direct immunofluorescence (DIF) pattern in pemphigus herpetiformis- A case report.
Kavita R; Sheenam A; Neelima B; Jitender BS
Indian J Pathol Microbiol; 2023; 66(4):852-854. PubMed ID: 38084547
[TBL] [Abstract][Full Text] [Related]
10. Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
Zhou X; Zhou Y; Qian H; Wu F; Liu H; Li X; Li W
J Dermatol; 2023 Oct; 50(10):e354-e356. PubMed ID: 37341162
[No Abstract] [Full Text] [Related]
11. A Case of Lamina Lucida-Type Linear IgA Disease Complicated by Colon Polyposis and Rectal Adenocarcinoma.
Miyazaki A; Itoi-Ochi S; Hayashi M; Ota A; Nagai K; Inoue S; Tomita N; Eguchi H; Okazaki Y; Ishida H; Hashimoto T
Case Rep Dermatol; 2023; 15(1):126-132. PubMed ID: 37899945
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Psoriasis and Bullous Diseases.
Dainichi T; Kabashima K
Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dtsch Dermatol Ges; 2024 May; 22(5):713-715. PubMed ID: 38593343
[No Abstract] [Full Text] [Related]
14. Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit.
Goletz S; Probst C; Komorowski L; Radzimski C; Mindorf S; Holtsche MM; Pigors M; van Beek N; Zillikens D; Schlumberger W; Schmidt E
Br J Dermatol; 2024 Mar; ():. PubMed ID: 38544457
[No Abstract] [Full Text] [Related]
15. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
16. Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview.
Chu KY; Yu HS; Yu S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743598
[TBL] [Abstract][Full Text] [Related]
17. Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.
Olbrich M; Künstner A; Witte M; Busch H; Fähnrich A
Front Immunol; 2019; 10():2327. PubMed ID: 31749790
[TBL] [Abstract][Full Text] [Related]
18. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
19. [Anti-p200 pemphigoid].
Holtsche MM; Goletz S; Zillikens D
Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
[TBL] [Abstract][Full Text] [Related]
20. Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.
Li Z; Jing K; Li S; Feng S
Postepy Dermatol Alergol; 2018 Aug; 35(4):338-343. PubMed ID: 30206444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
